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Abstract
Human lymphocyte antigen (HLA)-restricted CD8
+ cytotoxic T lymphocytes (CTL) target and kill HIV-infected cells expressing
cognate viral epitopes. This response selects for escape mutations within CTL epitopes that can diminish viral replication
fitness. Here, we assess the fitness impact of escape mutations emerging in seven CTL epitopes in the gp120 Env and p24
Gag coding regions of an individual followed longitudinally from the time of acute HIV-1 infection, as well as some of these
same epitopes recognized in other HIV-1-infected individuals. Nine dominant mutations appeared in five gp120 epitopes
within the first year of infection, whereas all four mutations found in two p24 epitopes emerged after nearly two years of
infection. These mutations were introduced individually into the autologous gene found in acute infection and then placed
into a full-length, infectious viral genome. When competed against virus expressing the parental protein, fitness loss was
observed with only one of the nine gp120 mutations, whereas four had no effect and three conferred a slight increase in
fitness. In contrast, mutations conferring CTL escape in the p24 epitopes significantly decreased viral fitness. One particular
escape mutation within a p24 epitope was associated with reduced peptide recognition and high viral fitness costs but was
replaced by a fitness-neutral mutation. This mutation appeared to alter epitope processing concomitant with a reduced CTL
response. In conclusion, CTL escape mutations in HIV-1 Gag p24 were associated with significant fitness costs, whereas most
escape mutations in the Env gene were fitness neutral, suggesting a balance between immunologic escape and replicative
fitness costs.
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Introduction
It is well established that the CTL response plays a major role in
control of both acute and chronic HIV-1 infection (reviewed in
[1]). Thus, numerous vaccine strategies are being evaluated to
elicit broad and potent CTL responses against HIV proteins [2].
However, a major obstacle is CTL-mediated selection leading to
viral escape, which occurs frequently in acute/early [3–8] and
chronic [9–11] infection. Recent studies have shown that CTL
selection is a major force driving viral evolution within individual
patients [12–14] and at the population level [15–18]. For some
epitopes, escape mutations are often slow to emerge, or even
absent despite strong specific CTL responses [13,19,20]. This rate
of CTL escape during infection may be influenced by mutational
pathways required for escape (e.g., requirements for transversion
versus transition and single versus multiple nucleotide mutations),
the killing efficiency (or ‘‘strength’’) of CTL responses [1] as well as
stochastic processes [21]. However, another often cited factor for
the slow appearance of CTL escape mutation may be the ‘‘cost’’
on replicative fitness of the infecting strain [22].
Several lines of experimental evidence have inferred fitness
costs. First, specific HIV-1 and SIV escape variants can be
maintained in viral populations after transmission to a host sharing
the restricting HLA allele, and revert to the consensus, epitopic
form when transmitted to an individual not sharing the donor
restricting HLA allele [13,23–25]. Thus, in the absence of specific
CTL responses, viruses with consensus amino acids are likely to
have higher replicative fitness. Second, some escape mutations can
be compensated by extra-epitopic mutations also under selection,
implying a fitness cost for the escape mutation [26–29]. Lastly,
introduction of CTL escape mutations into HIV-1 and SIV
epitopes has been shown to reduce replication kinetics [26,30–34].
Martinez-Picado et al. have provided evidence that a specific
T242N mutation in the TW10 Gag p24 epitope can reduce fitness
when introduced into the autologous (patient-derived) HIV-1
sequence [32]. However, the collective assumption that CTL
PLoS Pathogens | www.plospathogens.org 1 April 2009 | Volume 5 | Issue 4 | e1000365escape mutations result in fitness loss is mainly derived from
analyses of discrete mutations in Gag epitopes of heterologous,
laboratory HIV-1 strains.
We recently reported a comprehensive analysis of viral
evolution and CTL recognition in one subject over the first three
years of infection with clade B HIV-1 [13]. CTL epitopes were
characterized by IFN-c ELISPOT using consensus and autologous
peptides spanning the entire HIV-1 proteome during first three
years of infection [13]. In the current study, we assessed the fitness
cost of all 13 epitopic mutations observed in Gag p24 and Env
gp120. Multiple selective factors may shape viral evolution
especially in surface exposed envelope glycoproteins but in this
study, we examined the phenotypic effects of mutations that
emerge within or around CTL epitopes, and focused on those
conferring CTL escape. Replicative fitness was measured by
competing a virus with a CTL escape mutation in the autologous
virus backbone against its ‘‘parental’’ clone. In general, introduc-
tion of epitopic escape mutations into gp120 Env had either no
effect or enhanced ex vivo fitness, while a significant fitness loss was
evident with escape mutations into the autologous p24 Gag
sequence.
Results
Schema for producing autologous HIV-1 chimeras to test
fitness costs
Patient 1362 was recruited into the Seattle Acute Primary
Infection Cohort (PIC) 8 days post (onset) development of symptoms
(DPS) of primary HIV-1 infection (Figure 1). Twenty-five CTL
epitopeswereidentifiedover12timepointsduringthefirst3 yearsof
infection [13], and one-third of the amino acid sites identified as
undergoing selection were associated with mutational escape from
CTL. A total of 10 epitopes were detected in the Gag capsid protein
p24 and in the Env glycoprotein gp120 (Figure 2). One of six gp120
epitopes was found at the N-terminus [35] and was not part of the
cloned gp120 cassette used in this study. Escape mutations were
detected in two of the four Gag epitopes (at 580 and 769 DPS)
(Figure 2A) and in all five gp120 epitopes by 113 to 580 DPS
(Figure 2B). Position of these mutations and of the CTL epitopes in
the HIV-1 p24 and gp120 coding regions are illustrated inFigure2A
and C, respectively. Sites of predicted amino acid substitutions
within or near these epitopes were also mapped to the p24 [36] and
gp120 crystal structures [37] (Figures 2B and 3B, respectively). For
the current analyses, p24 and gp120 coding regions were PCR-
amplified from patient 1362 PBMC and then cloned into an HIV-1
NL4-3 background genome by yeast homologous recombination
(Figure 1, Figure S1 and Protocol S1 online) [38]. We have
previously reported on the cloning of two CTL escape mutations in
one of the p24 epitopes (EW10) [35]. However, competition and
fitness analyses were still repeated for these studies.
We first selected p24 and gp120 plasmid clones matching the
PIC1362 consensus HIV-1 sequence at 8 DPS and prior to the
appearance of CTL escape mutations. These clones served as the
autologous genetic backbone for introduction of CTL escape
mutations by site-directed mutagenesis. Chimeric NL4-3 harbor-
Figure 1. Experimental Strategy. In part 1, the days post onset of symptoms (DPS) viral genetic data was obtained from plasma in our previous
study. In addition, sequences were obtained from PBMC DNA from days 34 and 298 for the present study (part 2). The remaining parts of the Figure
outline the methods used to generate isogenic viruses and perform ex vivo competition assays in PBMC. Additional details are provided in Figure S1
and S2.
doi:10.1371/journal.ppat.1000365.g001
Author Summary
Upon infection with a pathogen, the host mounts an
immune response of specific killing by recognizing
infected cells presenting the foreign entity via host cell
surface proteins (aka MHC) encoded by specific HLA genes.
The pathogen’s proteins are chopped up into peptides
(short protein sequences) by cellular enzymes. Some of
these peptides are bound to MHC class I proteins and then
presented on the cell surface, signifying a pathogen
intrusion to the killer T cells (CTLs). In order to survive,
HIV-1 evolves to mutate the specific peptides (aka
epitopes) and escape recognition by MHC I and CTLs.
These ‘‘forced’’ or selected mutations are thought to come
at a cost, e.g., result in slower pathogen growth/
replication. Here, we show that the escape mutations in
HIV-1 genes showing slow evolution result in dramatic
losses in HIV-1 replication (or fitness). In contrast, CTL
escape mutations in HIV-1 genes with rapid evolution do
not have a negative impact on pathogen fitness. These
findings could suggest that HIV-1 (and possibly other
rapidly evolving pathogens) could avoid the host’s
immune system with minimal detriment to its own survival
and growth within the host.
CTL Escape and HIV-1 Fitness
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replication competent (see below), and mutations were introduced
into one epitope at a time for study. Epitopic mutations within
seven p24 and gp120 epitopes, corresponding to a total of 13 CTL
escape and secondary mutations appearing over the first three
years of infection, were introduced into the PIC1362 HIV-1
sequence alone or in combination to produce 6 NL4-3/p24 and
13 NL4-3/gp120 mutant chimeric viruses for fitness analyses (see
below). Full-length chimeric viruses were constructed, produced,
and quantified as outlined in Figure 1 (details provided in Figure
S1 online).
To measure replicative fitness, equal infectious units of viruses
harboring CTL escape mutations (in the vifA backbone) were
competed against the parental virus (vifB) in PBMC cultures. In
these dual infection/competition assays, the production of the vifA
virus, harboring six synonymous substitutions, can be differenti-
ated from the vifB virus using a quantitative heteroduplex tracking
assay (assay details and examples of results provided in Figure S2
online) [39,40]. To ensure that the vif substitutions did not impact
fitness, competitions were performed using NL4-3vifA and NL4-
3vifB virus harboring the same PIC1362 p24 (or gp120) sequence.
These viruses had equal fitness, confirming [39,40] that the vif
Figure 2. Mapping of the CTL escape and secondary mutations of PIC1362 onto the primary amino acid sequence and X-ray crystal
structures of the N-terminus of p24 Gag. CTL epitopes are mapped to the consensus amino acid sequences of p24 in panel (A) (shaded regions).
Amino acid positions are indicated using HXB2 amino acid numbering. Sites of mutations are depicted as space filled amino acids (those within the
epitopic form are shown) in X-ray crystallography-derived ribbon structure models of the N terminus p24 [36] (B). The ‘‘yellow’’ residues signify sites
at which no impact on replication fitness was detected and ‘‘pink’’ – decreased fitness (see Figure 4).
doi:10.1371/journal.ppat.1000365.g002
CTL Escape and HIV-1 Fitness
PLoS Pathogens | www.plospathogens.org 3 April 2009 | Volume 5 | Issue 4 | e1000365synonymous substitutions did not impair replication (grey bars in
Fig. 3 and see below) (p.0.1, n=8).
Effects of CTL escape mutations in the HIV-1 capsid
protein on replication fitness
Of the four CTL epitopes that mapped to p24, escape
mutations emerged in the two HLA-A25-restricted QW11 and
EW10 epitopes over the first 3 years of infection (Figure 2A), but
not in VL8 and FK10 epitopes (Figure 2A), despite strong CTL
responses during the 1035 days of follow-up [6] (and data not
shown). Failure to detect escape mutations in these epitopes may
be related to the defective phenotypes conferred by mutations [41]
as discussed below (Figure 2B).
An E207D mutation emerged within in the EW10 epitope at
580 DPS (Figure 4A), conferring escape (ratio of EC50 EW10/
EC50 E207D=27; Figure 4B). Interestingly, the E207D mutation
was accompanied by a V215L mutation, 3 amino acids C-terminal
to the epitope (Figure 4A). A significant decrease in replication
fitness was observed when E207D or the E207D/V215L double
mutation was evaluated (Figure 4B). However, the virus containing
the V215L mutation alone did not alter fitness. The E207D escape
mutation was not detected at 769 DPS, whereas the V215L
mutant was dominant at that time (Figure 4A). The proximity of
the V215L mutation to the EW10 epitope suggests that it may
have conferred CTL escape by impairing peptide processing [31],
allowing the epitopic sequence to re-emerge. Impact of E207D
and V215L on peptide processing is examined below.
To compare CTL escape patterns in EW10, we evaluated viral
sequences as well as IFN-c secreting T cell responses (as measured
by ELISpot) to EW10 in each of three other PIC subjects sharing
the same A25 HLA restricting allele (PIC1052, PIC1349, and
PIC1483) (Figure 5A and B). No mutations were observed in the
EW10 epitope of patients PIC1052 and PIC1349. However, these
patients were infected with virus containing the putative processing
mutation, 215L. This was not unexpected and has been noted
previously [35], the leucine at position 215 is the consensus amino
acid in HIV-1 subtype B (88% of sequences), whereas valine is
only found in 10% of HIV-1B sequences. Lack of ELISpot
responses to EW10 in PIC1052 and PIC1349 along with the
presence of 215L suggests the lack of peptide presentation. In
contrast, a CTL response was detected in PIC1483, who, like
PIC1362, was infected with virus bearing valine at position 215.
However, the PIC1362 T cell response to the EW10 peptide was
10-fold greater than that of PIC1483 T cell (Figure 5B). Reduced
CTL pressure and high fitness costs of EW10 escape variants
might explain for the lack of evolution within or the near vicinity
of the EW10 epitope of PIC1483 (Figure 5A). In another study
[42], EW10 was recognized (and not found to escape) in a subject
infected with a virus harboring the p24 215V allele (Figure 5A). In
summary, this data is consistent with the hypothesis that the
V215L mutation interferes with the presentation of the EW10
epitope – the epitope is recognized in three subjects that had the
rare valine in the C-terminal flanking sequence, but not in the
subjects that had the consensus leucine at this position.
Impact of CTL escape mutations on replicative fitness was also
assessed in the other recognized, HLA A25-restricted p24 epitope
of PIC1362. An I147L mutation was first detected in QW11 at
580 DPS (Figure 4C) but this did not confer an obvious escape
(ratio of EC50 QW11/EC50 I147L=0.6; Figure 4D) or a loss in
viral fitness (Figure 4D). However, by 769 DPS, an adjacent
mutant emerged (A146P) linked to I147L, that by itself was weakly
recognized by CTL (EC50 ratio=2.4), while drastically reducing
viral fitness (Figure 4D). The A146P/I147L QW11 peptide was
not recognized in ELISpot assays (Figure 4D). Although this
double mutant did restore some replicative fitness compared to
I147L alone, the virus harboring these mutations were still less fit
than the parental PIC1362 virus (Figure 4D). After 769 DPS, the
A146P/I147L double mutants were present in a minority of
sequences while the I147L mutation remained dominant
(Figure 4B). The I147L mutation may therefore provide a limited
degree of compensation for the fitness loss associated with the
escape mutant A146P, while facilitating epitopic escape.
To address the commonality of these observations, we assessed
the recognition and stability of the QW11 epitope in the same 3
additional HLA-A25 subjects from the PIC cohort. QW11 was
recognized by all three individuals, but at slightly lower levels
compared to that in PIC1362 (Figure 5D). PIC1349 developed the
same A146P/I147L double mutation observed in PIC1362
(Figure 5C). However, unlike PIC1362, both mutations dominated
in the HIV-1 population for an extended period (from 342
through at least 2025 DPS) (Figure 5C). It is important to note that
in the case of PIC1349, an overlapping epitope starting at position
A146 (AW10) could be recognized through the B*5801 allele
[43,44]. CTL escape from a B58 restricted response may also be
related to the emergence of A146P and/or I147L. It is not
surprising that same anchor residues may be mutated to confer
escape to an A25 and B58-restricted response. The I147L
mutation also emerged in PIC1483, although was only detected
at the last day of sampling (1546 DPS). Finally, in PIC1052, an
A146S mutation emerged at 184 DPS but disappeared by 754
DPS, at which time the R150T mutation was dominant
(Figure 5A). Thus, the QW11 epitope was recognized in all 4
HLA-A25 subjects and was a site of viral evolution in each case.
However, we did not determine the impact of these mutations on
CTL recognition nor on viral fitness. It should be noted that the
emergence of specific EW10 or QW11 mutations was not
associated with demonstrable increases in viral load or decreases
in CD4 cell counts in any of the 4 subjects (data not shown).
Peptide processing during evolution of the EW10 p24
epitope
Population dynamics of the HIV-1 p24 gag sequences within
PIC1362 has been previously characterized [35] and summarized
in Figure S3A online. The EW10 peptide dominated the
population over 550 DPS with a small fraction containing the
extra-epitopic mutation, V215L. A strong ELISpot response to the
EW10 peptide (2345 SFC/10
6 cells) was observed prior to the
emergence of the E207D mutation (Figure S3B online). While
mostly linked to V215L, E207D reached peak levels at ,50% of
the HIV-1 population around 713 DPS, which corresponded to a
reduction in ELISpot response (530 SFC/10
6 cells). This depletion
of PBMCs responsive to the EW10 in PIC1362 may be explained
by reduced ability to recognize the E207 peptide (Figure 4B). By
826 DPS, the loss of E207D was associated with a rebound in
EW10 ELISpot response (1400 SFC/10
6 cells) (Figure S3 online).
By 1035 DPS, all wild type EW10 sequence were linked to the
adjacent V215L mutation and over the next year and half, the
dominant V215L in the HIV-1 population corresponded to a
reduction in EW10 response (303 SFC/10
6 cells at 1329 DPS and
262 SFC/10
6 cells at 1501 DPS). Obviously, the extra-epitopic
V215L mutation cannot directly explain for the reduction in
PBMCs responding to the EW10 peptide. Alternatively, V215L
may alter processing of the EW10 peptide.
To test this hypothesis, three HIV-1 peptides harboring the
EW10 epitope were subject to both ex vivo cytosolic degradation
and in silico proteasome processing. NetChop 3.0 was used to
predict the proteosomal cleavage products generated from 27 and
40 mer peptides. These peptides used for the processing study
CTL Escape and HIV-1 Fitness
PLoS Pathogens | www.plospathogens.org 4 April 2009 | Volume 5 | Issue 4 | e1000365Figure 3. Mapping of the CTL escape and secondary mutations of PIC1362 onto the primary amino acid sequence and X-ray crystal
structures of the N-terminus of gp120 Env core. CTL epitopes are mapped to the consensus amino acid sequences of gp120 in panels (A)
(shaded regions). Amino acid positions are indicated using HXB2 amino acid numbering. Sites of mutations are depicted as space filled amino acids
(those within the epitopic form are shown) in X-ray crystallography-derived ribbon structure models of the gp120 core complexed to CD4 and an
anti-gp120 antibody [37] (D). The ‘‘yellow’’ residues signify sites at which no impact on replication fitness was detected, ‘‘pink’’ – decreased fitness,
and ‘‘blue’’ - increased fitness (see Figure 6).
doi:10.1371/journal.ppat.1000365.g003
CTL Escape and HIV-1 Fitness
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and I223V mutations found over the course of PIC1362 infection.
The program C-term 3.0 network is trained with a database
consisting of 1260 publicly available MHC class I ligands (using
only C-terminal cleavage site of the ligands). Overall, twelve
peptide products were predicted from wt 27 mer using NetChop
3.0 (Figure 6A, panel ii). The highest probabilities of cleavage
(threshold set at 0.5) were observed at the C-term of K202 and
W213 resulting in an intact EW10 peptide. A similar pattern of
peptide cleavage was observed when the algorithm was run on
longer wt peptides (data not shown). Relative proportion of
products can be predicted using NetChop 3.0 (Figure 6A, panels i).
The probability of cleavage at position A209 (within EW10) did
increase from 0.47 with the wt 27 mer (Figure 6A, i), to 0.51 with
E207D/V215L peptide (Figure 6B, i), and to a 0.64 cleavage
probability with the V215L/I223V peptide (Figure 6C, i).
Whereas NetChop3.0 predicts proteasomal cleavage sites,
cytosolic degradation assays take into account all peptidases
Figure 4. Ex vivo fitness, CTL escape phenotype and sequence evolution of gag p24 CTL escape mutants. The predicted amino acid
sequence derived from 11–12 clones at different DPS is presented for epitopes EW10 (A) and QW11 (C). The effect of each mutation, or combination
of mutations, on the CTL responses to the epitopic peptide in PIC1362 was assessed by ELISpot (grey box in panels (B) and (D)). The fold escape
conferred by each mutation is displayed here as the ratio of effective peptide concentration (EC50) required to elicit 50% of maximal ELISpot signal
relative to the pre-escape peptide [54]. EC50 values.10 were considered to indicate escape. The standard IFN-c Elispot assay was performed with the
defined optimal epitopic peptide at the following concentrations: 0.64, 3.2, 16, 80, 400, 2,000, and 10,000 ng/ml. The effective peptide concentration
that elicited 50% of the maximum T-cell response, defined as the EC50, was determined with the Sigmoidal Fit tool in the software. ELISpot assays not
done (ND) with some peptides. NR (no response) refers to a lack of response to a mutant peptide by ELISpot. A positive response was defined as
twice the negative control and .50 Spot Forming Cells (SFC)/10
6 cells. In the case where the wild type peptide was recognized and mutant peptide
did not induce a response, full escape (‘‘Full’’) was given as the value for the EC50 ratio. Mutations that conferred significant CTL escape are displayed
in red columns in (B) and (D). Mutations that did not confer significant escape are shown in green type in (A) and (C) and in green bars in (B) and (D).
Combinations of these mutations are shown in purple. CTL escape and associated mutations in the p24 coding sequence were introduced
individually and in combination into chimeric NL4-3 viruses bearing the consensus initial/infecting strain from 8DPS (Figure 1 and Figure S1). The
effect of these mutations was determined by direct competition with isogenic virus bearing the wild-type amino acid. The control involved
competitions between 8DPS-p24 virus competed against a virus of identical amino acid sequence (except for synonymous mutations in vif to
differentiate the viruses). These viruses were equally represented following dual infection and thus had equal fitness (relative fitness ,1) (gray bar in
(B) and (D)). Significance of any increase or decrease in fitness conferred by a mutation(s) was evaluated using Student’s t-test to compare the relative
amounts of each virus. Only p values,0.05 are displayed on the graphs and the 95% confidence interval of the mean is shown for each bar. Fitness
data presented on the EW10 epitope (B) have been previously published [35] but for this figure, all competitions were repeated in quadruplicate
resulting in very similar results.
doi:10.1371/journal.ppat.1000365.g004
CTL Escape and HIV-1 Fitness
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the production of epitopes and epitope precursors in the cytosol.
For this assay, a wt 27 mer peptide starting at position 200 in Gag
(position 66 in p24) was incubated with PBMC cytosolic extracts of
an HIV-negative donor for 10 and 60 min and then subject to
analyses by mass spectrometry [45]. Majority of peptides suggest
cleavage events at position 202 and 213 but with some further
trimming at the ends of the EW10 peptide (Figure 6A, ii). With the
E207D/V215L or V215L/I223V peptides, both predictive and ex
vivo processing suggest increased cleavage within the EW10, thus
destroying the epitope. Fewer peptide products were generated
from ex vivo processing of the E207D/V215L peptide as
compared to the V215L/I223V peptide (Figure 6B and C).
Unfortunately, the relative amounts of each cleavage product
could not be measured by MS. However, decreased EW10
presentation is likely due to the increased probability of cleavage in
EW10 with V215L (as predicted NetChop).
Based on these predictive algorithms and supported by ex vivo
processing results, enhanced cleavage in EW10 was observed in the
E207D/V215L double mutant. However, E207D alone, which was
rarely found in PIC1362, does not alter EW10 processing (data not
shown) based on predictive algorithms. Together, this data suggests
Figure 5. Sequence of p24 epitopes QW11 and EW10 in HLA-A25 patients with CD8+ T cell responses to these epitopes. The
consensus sequence at each timepoint was determined by bulk population nucleotide sequencing of the QW11 (A) and EW10 (C) epitopes of four
HLA A25-restricted patients, PIC1362, PIC1349, PIC1052, and PIC1483. The sequences of the QW11 and EW10 epitopes of PIC1362 are shown at the
top of panels A and C. The EW10 sequences from the ‘‘HLA-A25’’ patient subject at the bottom of panel C is from a previously published study [42].
The shaded amino acids refer to CTL escape mutations. Non-shaded epitopic mutations were associated with escape but confirmatory CTL
recognition assays were not performed. ELISpot assays were performed with the QW10 and EW10 peptides and PBMC from multiple time points from
PIC1362, PIC1349, PIC1052, and PIC1483 (B and D). NR refers to no detectable IFN-c ELISpot response.
doi:10.1371/journal.ppat.1000365.g005
CTL Escape and HIV-1 Fitness
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augments cleavage within the EW10 epitope of HIV-1 p24. As
discussed below, it is important to note that the V215L does not
abolish the presentation of the EW10 peptide, which might explain
for the slow reduction and retention of some EW10-responsive
PBMCs after a year and half of V215L dominance in the HIV-1
population of PIC1362 (Figure S3B online).
Effects of CTL escape mutations in the HIV-1 envelope
glycoprotein on replication fitness
In stark contrast to the results for the p24 mutants, escape
mutations in four (YW9, NW9, YL10, EY10, TL9) of five gp120
epitopes (Figure 7A, E, G, and I respectively) resulted in either no
change in fitness or small, but statistically significant increases in
fitness (Figure 7B, F, H, and J). Although escape mutations in the
YW9, NW9, and YL10 epitopes appeared as early as 155 DPS in
the virus population, escape mutations in EY10 and TL9 did not
emerge until 580 DPS or around the same time frame as escape
mutation in the Gag p24 epitopes, EW10 and QW11. In the case
of YW9, two epitotic mutations evolved independently starting at
50 DPS (Figure 7A). The fitness neutral V65A virus may present a
YW9 mutant peptide with enhanced CTL recognition based on
ELISpot whereas E62D and E62D/V65A viruses, both with
increased fitness, displayed peptides modestly (EC50 ratio=13-
fold) and were highly resistant (EC50 ratio.83 [13]) to CTL
recognition, respectively (Figure 7B). Thus, the linkage of the
E62D and V65A not only increased resistance to CTL pressure
but also encoded for a more fit virus over V65A alone. However,
apparent lack of CTL escape with V65A in YW9 (Figure 7A and
B) as well as E322D in EY10 (Figure 7G and H; see below)
suggests that these mutations may alter processing, MHC class I
presentation, or may even emerge in response to another selective
pressure such as humoral response. In particular, the E322D
mutation within the EY10 epitope also maps to the base of the V3
loopandjustadjacenttothecrownofthisloop(Figure3AandB),i.e.
a highly immunodominantregion for antibodyresponse. In contrast,
V65A is found at the N-terminal end of a putative T-Helper/CD4+
epitope, H-2bxk or H-2sxd (Los Alamos HIV Molecular Immunol-
ogy Database; www.hiv.lanl.gov/content/immunology). HLA class
II alleles were not identified in this patient. Aside from these two
mutations, CTL escape was conferred by the other seven mutations
in CTL epitopes within gp120.
AsimilarpatternofepitoticmutationsevolvedinEY10(Figure7G
and H). The first escape to appear was E322D (Figure 7G) with a
minimal reduction in CTL recognition and without a fitness cost
(Figure 7H). Subsequently (580 DPS), the C-terminal Y330H
Figure 6. Predicted and ex vivo processing of peptides
harboring the EW10 epitope. Peptides of 27 amino acids in length
and representing positions 200 to 226 in the Env gp120 sequence were
used in silico in the NetChop 3.0 C-term peptide processing algorithm
(http://www.cbs.dtu.dk/services/NetChop/). C-term 3.0 network is
trained with a database consisting of 1260 publicly available MHC
class I ligands (using only C-terminal cleavage site of the ligands). The
probability of cleavage at each amino acid (panel i) is presented for wt
27 mer peptide (A) and peptides containing the E207D/V215L (B) or
V215L/I223V (C). The cleavage peptide products were predicted based
on a program recommended probability of cleavage (above a 0.5
threshold, black bars). Low probabilities of cleavage (below 0.5) were
presented in grey bars. The same three 27 mer peptides were also
synthesized and subject to protease processing using cytosol prepa-
ration from HIV-negative PBMCs. Panel ii displays the peptides derived
from the wt (A), E207D/V215L (B) or V215L/I223V (C) and identified by
mass spectrometry.
doi:10.1371/journal.ppat.1000365.g006
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(Figure 7G). Although the double mutant displayed increased fitness
and conferred modest escape (Figure 7H), it was eventually
overgrown by a fitness-neutral Y330H virus that appeared fully
resistant to the EY10 CTL response.
Single CTL escape mutations appeared in YL10 and TL9
epitopes and dominated in all subsequent time points (Figure 7E
and I, respectively). The L226I in YL10 did not significantly
impact fitness (Figure 7F) whereas the Q344K in TL9 resulted in a
30% increase in replicative fitness (p,0.001) (Figure 7J).
In the fifth gp120 epitope, NW9, three persistent mutations
were evaluated (Figure 7C), all of which conferred full escape
(Figure 7D). The first to appear was N94D, which resulted a slight
but significant decrease in fitness. Next to appear was N92D,
which did not impact replicative fitness. The transient linkage of
N92D and N94D resulted in the largest loss in fitness (Figure 7D).
The N92E mutation, first detected at 344 DPS, replaced the
N92D by 769 DPS in the virus population and then dominated
with N94D (Figure 7C). This N92D/N94E combination restored
viral fitness (Figure 7D). Thus, the virus appears to evolve into a
form that escaped with poor fitness to one that retained immune
escape but improved viral fitness. It is also interesting to note that
the mutations at position 92 appeared to evolve sequentially - a
single transition mutation was required for the N (AAT) to D
(GAT) substitution, whereas a further transversion mutation was
necessary to change D to E (GAG and GAA). This might explain
why the N92D/N94D escape variant of low fitness emerged prior
to the fitness neutral escape variant (N92E/N94D) (Figure 7C).
Discussion
Evaluation of viral replicative fitness, commonly defined as
relative viral replication success within cell culture, is becoming an
important tool for the ex vivo study of host-virus interactions
(reviewed by [46]). Several recent studies have shown or implied
that CTL escape mutations can result in a loss of viral fitness [23–
27,31–34]. Our studies have improved upon this prior work by
coupling longitudinal analysis of specific CTL escape/secondary
mutations with their effects on replicative fitness. Instead of
assessing the effects of single, discrete CTL escape mutations in a
heterologous HIV-1 backbone, replicative fitness in this study was
assessed with virus containing the autologous Gag p24 and Env
gp120 sequences and the specific epitotic mutations as they
appeared in the patient.
We found that the characteristics and impact of escape
mutations differed between Gag p24 and Env gp120. Relative to
those in p24, CTL escape mutations in gp120 appeared earlier
(Figure 6), were more likely to give rise to full epitopic escape, and
did not substantially diminish viral fitness. These findings uncover
a dynamic evolutionary process of fitness-balanced CTL escape
that is suggestive of several mechanistic pathways of viral
adaptation to the host immune response.
First, the emergence rate of escape may be associated with the
impact on viral fitness – the slower the appearance of escape, the
greater the associated fitness cost. This is in agreement with
previous studies that have shown that CTL escape mutations
emerge more rapidly in less conserved genes of the virus [3]. For
example, CTL escape mutations in HIV-1 Tat during asymp-
tomatic disease had a neutral effect on Tat activity [47].
Differences in the appearance of CTL escape mutations have
also been attributed to the processing of HIV-1 proteins found in
early versus later stages of the retroviral life cycle [3,6]. However,
the latter hypothesis does not explain the early appearance of
gp120 escape mutations, as gp120 is also a late protein in the
retrovirus life cycle. Escape mutations did appear within the first
155 DPS within the Env YW9, NW9, YL10 and at least a year
before the emergence of escape mutations in the Gag EW10 and
QW11 epitopes. However, CTL escape was notably delayed in
two other Env CTL epitopes. This delay in escape may have been
associated with a weak CTL response to the wild type EY10 and
TL9 epitopes (Figure 7).
Second, secondary mutations within and surrounding CTL
epitopes tended to enhance viral fitness while maintaining or
enhancing immunological escape. In the case of Env, the primary
CTL escape mutations that appeared in 4 of 5 gp120 epitopes had
a neutral or slightly positive impact on replication fitness.
Subsequent mutations at the same or second sites within the
epitope sometimes demonstrably enhanced escape and/or in-
creased replication fitness (e.g., Y65A in YW9, Y330H in EY10).
A similar pattern of eventual enhancement of viral fitness was even
observed in the NW9 gp120 epitope where initial CTL escape
mutations resulted in a slight fitness loss, but these amino acids
were then replaced by those that enhanced fitness while
maintaining escape. In the case of Gag, escape at the EW10
CTL epitope resulted in a significant loss in fitness. However, it
was quickly compensated for by a V215L change C-terminal to
the epitope. The latter change did not improve fitness, rather it
appeared to restrict presentation of the epitope through a
processing defect, allowing the epitopic escape mutation to revert
back to the sensitive form. This hypothesis is supported by (1)
prediction and direct evidence of increase cleavage within the
EW10 epitope in the presence of V215L, (2) T cell responses (as
measured by ELISpot) against EW10 in two HLA-A25 individuals
with the epitope predicted to be in a ‘‘presentable’’ configuration,
i.e., with valine at position 215, and by (3) the lack of T cell
responses against EW10 in another two HLA-A25 individuals with
leucine at this position, the putative configuration that disrupts
processing [31]. It should be noted leucine is a more common
amino acid at position 215 in the HIV-1 sequence database (89%
L, 10% V), suggesting that this epitope is unfortunately
unavailable to the immune recognition in most HIV-1 infected
individuals. Although an EW10 processing defect is likely with
V215L, T cell recognition of target cells synthesizing intact and
mutant epitopes will be necessary to firmly establish this point.
Third, CTL escape mutations and secondary mutations in the
EW10 and QW11 sites emerged in regions of the p24 protein
accommodating some genetic change as opposed to more
functionally conserved sites. In general, p24 mutations in N
terminal b hairpin/helix 1 (site of CTL epitope, QW11) and in
helix 4 (site of EW10) [36] (Figure 2B) do not alter virus core
morphology or assembly based on a study by von Schwedler et al.
2003 [41]. In contrast, gross disruptions in virus core structure and
drastic decreases in infectivity were associated with mutations in
Figure 7. Ex vivo fitness, CTL escape phenotype and sequence evolution of env gp120 CTL escape mutants. The predicted amino acid
sequences for 10–16 clones from different DPS from subject 1362 are presented for epitopes YW9 (A), NW9 (C), YL10 (E), EY10 (G), and TL9 (E). The
effect of each mutation or combination of mutations on the CTL response to the mutant peptide was assessed by ELISpot (grey box in panels B, D, F,
H, and J, respectively). ELISpot and EC50 concentrations were determined as described in the legend to Figure 4. Mutations that confer significant CTL
escape are displayed in red text and bars in the respective panels. Mutations that did not confer significant escape are shown in green. Combinations
of these mutations are shown in purple. Control experiments (gray bars) and significance testing were as described in the legend to Figure 4.
doi:10.1371/journal.ppat.1000365.g007
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(Figure 2B) [41]. This study may provide preliminary evidence as
to why escape variants do not emerge in the VL8 and FK10
epitopes of PIC1362 despite strong CTL recognition for at least
three years of infection [6]. Further structural/functional analyses
are required to define the impact of these mutations on specific
perturbations in p24 structure and defects in various p24 functions
during virus replication. Finally, in support of this structural
constraint for CTL escape in Gag, recent studies on SHIV
evolution in macaque infections suggest that evolutionary
pathways to CTL escape is more restricted with gag than with
env [48].
Recent findings have correlated lower viral loads with CTL
responses directed against the more conserved Gag rather than
those directed against the more heterogeneous Env [49].
Furthermore, responses against subdominant viral epitopes are
more closely related to virologic control than immunodominant
epitopes [50]. However, our recent results have shown that Env is
a CTL target that has been under-appreciated due to the lack of
consensus peptide sets that accommodate its very high level of
diversity [13]. Furthermore, there are obviously overlaps between
MHC class I and II epitopes in env which may influence env versus
gag evolution. The current study reconciles these observations
through demonstration that CTL responses against Env, however
immunodominant early in infection, may have little impact on
virus fitness and thus contribute little to virologic control (Figure
S4 online). Furthermore, any viral load decreases due to CTL
pressure directed against gp120 may be quickly eroded due to
rapid epitopic escape and emergence of compensatory mutations.
Thus, sustained virological control exerted by CTL is likely due to
continued immune pressure on the more structurally constrained
viral proteins, e.g., in the Gag p24 protein. Ultimately,
maintenance of HIV-specific CTL pressure may be indirectly
governed by replicative fitness. Continued virologic suppression
during asymptomatic infection and slow emergence of epitopic
escape mutations in Gag is likely due to the consequence of their
high fitness costs.
Materials and Methods
Study subjects and specimens
Study subjects PIC1362, PIC1349, PIC1052 and PIC1483 were
participants in a natural history study at the University of
Washington Primary Infection Clinic (PIC). HLA alleles were
determined by allele-specific PCR to be A*0201, A*2501, B*1801,
B*5101, Cw*0102, Cw*1203 for PIC1362 [6]; A*02, A*25, B*58,
B*62 (likely 1501), Cw*04, Cw*07 for PIC1349; A*25, A*30,
B*07, B*35, Cw*04, Cw*07 for PIC1052; and A*0101, A*2501,
B*3801, B*3901, Cw*1203, Cw*1203 for PIC1483. Virologic,
immunologic, and other clinical parameters of PIC1362 have been
reported previously [6,13]. For the current study, viral DNA was
obtained from PIC1362 PBMC at 34 and 298 days post onset of
acute symptoms of primary HIV infection (DPS). This study was
approved by the Institutional Review Boards of the University of
Washington, Fred Hutchinson Cancer Research Center, and Case
Western Reserve University, and all subjects provided informed
consent for participation in the study.
Construction and propagation of chimeric HIV-1
The gp120-encoding region of env (nucleotides 6347–7802,
HIV-1HXB2) and the p24-encoding region of gag (nucleotides
1089–2022, HIV-1HXB2) of the initial/infecting strain (IS) were
PCR amplified from PBMC DNA of PIC1362 at 34 and 298 DPS,
respectively. PCR reactions were conducted using PlatinumH Taq
DNA Polymerase High Fidelity following the manufacturer’s
recommendation (Invitrogen). Primers ENV START and ED12-
EXT [38], and GAD5 and GAD4 (Table S1 online) were used for
the gp120 and p24 amplifications, respectively.
PCR products were inserted into two versions of the NL4-3
HIV-1 molecular clone, pNL4-3vifA and pNL4-3vifB, differing at
only six synonymous nucleotides in the HIV-1 vif gene, using a
previously described yeast-based recombination system [38]
(Figure S1 online).
Infectious HIV-1 chimeras were produced by transfection of
NL4-3/gp120 and NL4-3/p24 into 293T cells as previously
described [38]. NL4-3/p24 viruses were briefly propagated
(#10 days) on U87.CD4.CXCR4 cells. NL4-3/gp120 viruses
were briefly propagated on U87.CD4.CCR5 cells since each
PIC1362 env gene examined from this subject had been found to
be genotypically R5-tropic [13]. Infections were monitored by a
reverse transcriptase (RT) activity assay and supernatant was
collected at peak RT activity (#10 days) and frozen at 2140uC.
Infectious virus TCID50 [51] were determined on phytohemag-
glutinin (PHA) and interleukin-2 (IL-2) stimulated PBMC as
previously described [52].
In order to test for genetic stability during replication, each virus
was used to infect 100,000 PHA and IL-2 stimulated PBMC [52]
in triplicate at an MOI of 0.005. After 10 days, DNA was
extracted from infected cells and the p24 and gp120 regions of
proviral DNA were PCR amplified as previously described [52],
with primers Gseq1 and Gseq2 for p24 and primers Eseq1 and
Eseq2 for gp120. Sequence analysis on these PCR products
confirmed that in all cases, the proviral sequences were identical to
that of the infecting virus, i.e., none of the CTL escape mutations
in NL4-3/gp120 or NL4-3/p24 viruses reverted to the pre-escape
amino acids during the 10 day infection.
HIV fitness and competition assays
Dual infection and competition assays were conducted as
previously described [52,53]. Dual virus detection by vif
synonymous substitutions has been recently described [39,40].
Details of this competition and dual virus detection as pertaining
to this study are provided in Figure S2 online.
HIV-1 population sequencing
Detailed clonal nucleotide sequencing of PIC1362 HIV-1
populations was described previously by Liu et al. [13]. Population
nucleotide sequencing of HIV-1 Gag p24 was performed for this
study on plasma and PBMC of PIC1349, PIC1052 and PIC1483.
Briefly, HIV-1 RNA was extracted from plasma using the
QIAamp Viral RNA Mini Kit (Qiagen) and PBMC DNA
containing HIV-1 provirus was extracted using the QIAamp
DNA Blood Mini Kit (Qiagen). PCR and RT-PCR were
conducted as previously described [52] with first external primers
RTG1 and RTG2 followed by internal primers RTG3 and RTG4
(Table S1). Nucleotide sequencing was performed by Davis
Sequencing, Inc. using an ABI 3700 DNA sequencer and
sequence chromatograms were examined using BioEdit v. 5
(Tom Hall, North Carolina State University).
Peptide processing ex vivo and in silico
Peptides of 27 and 40 amino acids in length and representing
positions 200 to 226 (or positions 195 to 234) in the Env gp120
sequence were used in silico in the NetChop 3.0 C-term peptide
processing algorithm (http://www.cbs.dtu.dk/services/NetChop/).
C-term 3.0 network is trained with a database consisting of 1260
publicly available MHC class I ligands (using only C-terminal
cleavage site of the ligands).
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or harboring the E207D/V215L or V215L/I223V mutations were
synthesized by Bio-Synthesis Inc, (Lewisville, TX). Purity (.95%)
and peptide sequences were confirmed by mass spectrometry
analysis. Cytosol from PBMC of healthy donors was prepared in
detergent-free buffer by breaking cells with glass beads and purified
by mutiple centrifugations as described previously [45]. Protein
concentration and content as well as antigen processing activities
were checked by Western blot and enzymatic assays as described
previously [45]. 8 nmol of purified peptides were degraded with
40 mg cytosol at 37uC for up to 60 minutes. The peptides present in
the digestion mix at different time points were identified and
quantified by reverse-phase high pressure liquid chromatography
(RP-HPLC) and mass spectrometry (Taplin Mass Spectrometry
Facility, Harvard Medical School) [45].
Online supplemental material
A detailed graphical description of the methods for clonal
sequence analyses, putative CTL escape peptide testing, produc-
tion of infectious chimeric viruses and introduction of escape
mutations is provided in Figure S1 online. Details of virus
competitions and dual virus detection conducted in this study are
provided in Figure S2 online. Nucleotide sequences of primers
used in this study are provided in Table S1 online.
Supporting Information
Figure S1 Detailed strategy for analyzing patient 1362 CTL
escape, sequence evolution and ex vivo HIV-1 fitness. Steps 1 to 5
have previously been reported by Liu et al.[13].
Found at: doi:10.1371/journal.ppat.1000365.s001 (1.11 MB PDF)
Figure S2 Competitive ex vivo HIV-1 fitness assay. Initial/
infecting strain (IS) and mutant chimeric viruses in the vif B and vif
A backgrounds, respectively, were competed in dual infections and
replicated as monoinfections at an MOI of 0.005 (A). The resulting
proportions of IS vif B and mutant vif A were determined by
heteroduplex tracking assay (HTA) targeting the vif gene (B).
Proviral DNA was amplified by nested PCR and these products
were annealed to a
32P radiolabeled probe complementary to
either the vif A or vif B sequence. Differences in the vif sequence at
the 59 end of the probe cause the heteroduplex (probe vif B
annealed to vif A DNA) to migrate more slowly in a
polyacrylamide gel, compared to the homoduplex (probe vif B
annealed to vif B DNA). HTA results for competitions of gp120-IS
(vif B) against gp120 NW9 epitope mutants (vif A) are displayed
using the vif B probe (C). Relative fitness (w) was then calculated
from the intensity of the virus-specific bands in competition in
relation to the intensity of the monoinfection bands as described
here (D) and previously [36,53]. Relative fitness values for the
mutant viruses were then plotted such that w.1 indicates greater
fitness of the mutant while w,1 indicates greater fitness of the IS
(E). The gray bar indicates the control in which gp120-IS in the vif
A and vif B backgrounds were competed against each other,
resulting in a nearly equal relative fitness (w=1).
Found at: doi:10.1371/journal.ppat.1000365.s002 (2.94 MB PDF)
Figure S3 Evolution of the EW10 peptide and ELISpot response
in PIC1362. (A) The relative proportions of the E207D and
V215L in the HIV-1 population of PIC1362 has been previously
published but presented in this panel to compare with (B) the
ELISpot responses to 2 mg/ml of the EW10 peptide in PBMCs
derived from 496, 713, 826, 1329, and 1501 DPS.
Found at: doi:10.1371/journal.ppat.1000365.s003 (0.33 MB PDF)
Figure S4 Timing of the first detected appearance of CTL
escape mutations in p24 and gp120 relative to patient viral load
and CD4 cell count. Plasma viral load and CD4 cell count are
shown relative to the days post acute symptoms (A). On the same
scale, relative ex vivo fitness of each p24 and gp120 CTL escape
mutation observed in patient 1362 is shown at the timepoint of its
first detection by clonal sequencing (B).
Found at: doi:10.1371/journal.ppat.1000365.s004 (0.61 MB PDF)
Table S1 Primers used in this study.
Found at: doi:10.1371/journal.ppat.1000365.s005 (0.04 MB
DOC)
Protocol S1 Supplementary methods.
Found at: doi:10.1371/journal.ppat.1000365.s006 (0.04 MB
DOC)
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